| Real-world characterization of blood glucose control and insulin use in the intensive care unit L Baker, JH Maley, A Arévalo, F DeMichele III, R Mateo-Collado, ... Scientific Reports 10 (1), 10718, 2020 | 23 | 2020 |
| Racial And Ethnic Disparities In COVID-19 Booster Uptake: Study examines racial and ethnic disparities in the uptake of COVID-19 booster shots. L Baker, B Phillips, LJ Faherty, JS Ringel, AM Kranz Health Affairs 41 (8), 1202-1207, 2022 | 22 | 2022 |
| Modeling COVID-19 nonpharmaceutical interventions: exploring periodic NPI strategies R Vardavas, PN de Lima, L Baker MedRxiv, 2021 | 20 | 2021 |
| The health and economic impacts of nonpharmaceutical interventions to address COVID-19: a decision support tool for state and local policymakers R Vardavas, A Strong, J Bouey, J Welburn, P de Lima, L Baker, K Zhu, ... (No Title), 2020 | 18 | 2020 |
| Artificial intelligence applications used in the clinical response to COVID-19: A scoping review S Mann, CT Berdahl, L Baker, F Girosi PLOS Digital Health 1 (10), e0000132, 2022 | 13 | 2022 |
| Data-driven curation process for describing the blood glucose management in the intensive care unit A Robles Arévalo, JH Maley, L Baker, SM da Silva Vieira, ... Scientific Data 8 (1), 80, 2021 | 13 | 2021 |
| Strategies to improve the impact of artificial intelligence on health equity: Scoping review CT Berdahl, L Baker, S Mann, O Osoba, F Girosi JMIR AI 2, e42936, 2023 | 10 | 2023 |
| Reopening California: Seeking robust, non-dominated COVID-19 exit strategies P Nascimento de Lima, R Lempert, R Vardavas, L Baker, J Ringel, ... Plos one 16 (10), e0259166, 2021 | 10 | 2021 |
| Modeling infectious behaviors: the need to account for behavioral adaptation in COVID-19 models R Vardavas, PN de Lima, PK Davis, AM Parker, L Baker Policy and complex systems 7 (1), 21, 2021 | 8 | 2021 |
| The US equity-first vaccination initiative: early insights LJ Faherty, JS Ringel, MV Williams, AM Kranz, LG Perez, LB Schulson, ... RAND, 2022 | 6 | 2022 |
| The US Equity-first vaccination initiative: impacts and lessons learned LJ Faherty, JS Ringel, AM Kranz, L Baker, B Phillips, MV Williams, ... Rand Health Quarterly 10 (2), 2023 | 5 | 2023 |
| The health and economic impacts of nonpharmaceutical interventions to address covid-19 R Vardavas, A Strong, J Bouey, JW Welburn, PN de Lima, L Baker, K Zhu, ... RAND Report TLA 173, 2020 | 5 | 2020 |
| Deep Generative Modeling in Network Science with Applications to Public Policy Research GS Hartnett, R Vardavas, L Baker, M Chaykowsky, CB Gibson, F Girosi, ... arXiv preprint arXiv:2010.07870, 2020 | 4 | 2020 |
| Increasing Subsidies and Expanding Health Insurance Options in Connecticut P Rao, F Girosi, R Vardavas, L Baker, C Eibner Rand Health Quarterly 9 (4), 2022 | 3 | 2022 |
| Could periodic nonpharmaceutical intervention strategies produce better COVID-19 health and economic outcomes? R Vardavas, PN de Lima, L Baker Policy and complex systems 7 (1), 81, 2021 | 3 | 2021 |
| An Evaluation of Crime-Free Housing Policies M Griswold, SB Holliday, A Sizemore, C Ren, L Baker, K Howell, O Osoba, ... RAND, 2023 | 1 | 2023 |
| Reopening Under Uncertainty: Stress-Testing California's COVID-19 Exit Strategy PN de Lima, R Vardavas, L Baker, JS Ringel, RJ Lempert, CM Rutter, ... Rand health quarterly 9 (3), 2022 | 1 | 2022 |
| There’s No Perfect Way To Measure COVID-19 Vaccination Equity, But Here’s Where To Begin B Phillips, L Baker, JS Ringel, LJ Faherty, AM Kranz Health Affairs Forefront, 2022 | 1 | 2022 |
| Early insights from the Equity-First Vaccination Initiative AM Kranz, L Perez, LJ Faherty, MV Williams, L Baker, P Gandhi, B Phillips, ... RAND Corporation, 2021 | 1 | 2021 |
| Characterisation of glucose management in intensive care L Baker Massachusetts Institute of Technology, 2019 | 1 | 2019 |
